FOR NEEDS OF THE EUROPEAN PARLIAMENT, independent of our will, the time of the press conference on wednesday 26th november has been changed to 2:00 p.m.of the same day.

 

New PRESS RELEASE (21.11.14)

 

The European Citizens’ Initiative STOP VIVISECTON

has collected

 

1,170,326

certified signatures

 

which will be presented to the european Commision in conjunction with the

 

Press conference to be held at the

 

european Parliament in Strasbourg

 

on wednesday 26th november 2014, at 2:p.m.

 

Certified by the national Authorities of all the EU member states, these signatures testify to the strong will of european citizens, and many of their politicians, to put an end to animal testing and to replace it with scientifically based biomedical research, with a view to effectively addressing, on a global scale, the urgent needs of human health in relation to the risk of chemicals.

During the press conference representaives of the scientific Committeee of Stop Vivisection (*) will explain the scientific and economic background to this very successful european Citizens’ Initiative. This will include the details of the heailth issues that affect all of us,

Convened by the members of Parliament Fabio Massimo Castaldo (M5S) and Michèle Rivasi (the Greens) the press conference will present scientific documents relevant to the issues of animal testing and to the need to use non-animal replacement methods, like tiered testing strategy, which are by far more reliable and relevant for the human species, as much as faster and cheaper; allowing thus  scientific progress to happen in biomedical research.

Also to be explained are the next steps of the Initiative.

The conference will take place in the Press conference room of the european Parliament, In Strasbourg.

It will begin at 2:00 p.m. and last 30 minutes, until 2:30 p.m.

 

Contact for more information (english, french):

 

Flavien Deltort: 0032 472670070 - 0032 22847478

 

or visit     <www,stopvivisection.eu>

 

__________________________________________

(*)

Andrè Ménache, United Kingdom: zoologist and veterinarian surgeon , director general of Antidote Europe.

 

Claude Reiss, France: physicist and cellular biologist, laboratory director for 30 years at CNRS of Paris and at Jacques Monod Institute, professor at the University of Lille, president of Antidote Europe.

 

Gianni Tamino, Italy: professor of biology at the University of Padua, former member of the european and of the italian Parliaments, president of EQUIVITA scientific Committee.

­­­­­____________________________________________________